logo

Cassava Sciences Inc (SAVA)



Trade SAVA now with
  Date
  Headline
1/28/2020 8:18:56 AM Cassava Sciences Initiates Dosing For Last Patient In Phase 2b Study Of PTI-125
9/16/2019 8:39:39 AM Cassava Sciences Initiates Phase 2b Clinical Study In Alzheimer’s Patients
9/9/2019 7:48:15 AM Cassava Sciences Reports Positive Top-line Clinical Results Of PTI-125
  
 
>